MIRM

NASDAQ · Biotechnology

Mirum Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$94.01

-2.96 (-3.05%)

As of Nov 5, 8:06 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -29.0% upside

Low Target $36.90

Average Target $66.73

High Target $76.87

Current Price $94.01

Current
$94.01

Target
$66.73

$36.90 $66.73 avg $76.87

Scenario Analysis

Bear Case

$36.90

-60.7%

Low target

Base Case

$66.73

-29.0%

Avg target

Bull Case

$76.87

+-18.2%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$130.00

-27.7% from high

52-Week Low

$63.23

+48.7% from low

50-Day SMA

$89.51

+5.0% vs SMA

200-Day SMA

$98.54

-4.6% vs SMA

RSI (14)

73.4

Overbought

Target vs 52W High

$66.73

-48.7% vs high

Next Earnings Report

Nov 17, 2026 · After Market Close

10d

until earnings

EPS Est: $-0.52

Earnings in 10 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-10.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+116.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	35%	$149.45	-38.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-60.7%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-35.8%